BOLT - Bolt Biotherapeutics, Inc. Stock Price and Quote

BOLT [NASD]

Index	-	P/E	-	EPS (ttm)	-2.55	Insider Own	9.80%	Shs Outstand	37.45M	Perf Week	-8.84%
Market Cap	52.88M	Forward P/E	-	EPS next Y	-2.04	Insider Trans	0.00%	Shs Float	35.19M	Perf Month	-15.19%
Income	-95.30M	PEG	-	EPS next Q	-0.60	Inst Own	68.00%	Short Float / Ratio	4.25% / 5.22	Perf Quarter	4.69%
Sales	4.80M	P/S	11.02	EPS this Y	-57.70%	Inst Trans	-0.16%	Short Interest	1.50M	Perf Half Y	-23.43%
Book/sh	5.03	P/B	0.27	EPS next Y	15.00%	ROA	-34.80%	Target Price	5.00	Perf Year	-54.11%
Cash/sh	4.34	P/C	0.31	EPS next 5Y	-	ROE	-43.60%	52W Range	1.18 - 3.14	Perf YTD	3.08%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-37.10%	52W High	-57.32%	Beta	-
Dividend %	-	Quick Ratio	7.20	Sales past 5Y	-	Gross Margin	-	52W Low	13.56%	ATR	0.10
Employees	91	Current Ratio	7.20	Sales Q/Q	162.50%	Oper. Margin	-	RSI (14)	41.87	Volatility	6.02% 7.39%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	7.60%	Profit Margin	-	Rel Volume	0.26	Prev Close	1.31
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	286.84K	Price	1.34
Recom	2.00	SMA20	-11.14%	SMA50	-9.65%	SMA200	-19.97%	Volume	74,037	Change	2.29%

Jan-06-22

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Mar-02-21

Initiated

SVB Leerink

Outperform

$36

Mar-02-21

Initiated

Stifel

Buy

$40

Mar-02-21

Initiated

Morgan Stanley

Overweight

$45

Mar-02-21

Initiated

Guggenheim

Buy

$42

Mar-14-23 04:30PM	Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual Meeting GlobeNewswire +7.86%
Feb-28-23 08:00AM	Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference GlobeNewswire
Feb-01-23 08:00AM	Bolt Biotherapeutics to Present at February Investor Conferences GlobeNewswire
Jan-04-23 09:31AM	Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation Simply Wall St.
Dec-14-22 04:43PM	Bolt Biotherapeutics Appoints Laura Berner to Board of Directors GlobeNewswire
04:05PM	Loading…
Nov-10-22 04:05PM	Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
Nov-07-22 08:00AM	Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting GlobeNewswire
Nov-02-22 07:20AM	Investors in Bolt Biotherapeutics (NASDAQ:BOLT) have unfortunately lost 89% over the last year Simply Wall St.
Nov-01-22 10:01AM	Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy? Zacks
08:00AM	Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference GlobeNewswire
Sep-09-22 12:08PM	16 Best Penny Stocks to Buy Now Insider Monkey
Aug-31-22 07:30AM	Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference GlobeNewswire
Aug-25-22 12:23PM	Eli Lilly (LLY) Stock Up More Than 15% YTD: What Lies Ahead? Zacks
12:02PM	J&J (JNJ) Gets EU Nod for Multiple Myeloma Drug Tecvayli Zacks
Aug-10-22 04:05PM	Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update GlobeNewswire +10.53%
08:44AM	Loading…
Jul-22-22 08:44AM	Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans? Simply Wall St. -5.75%
Jun-10-22 07:21AM	Zacks.com featured highlights include Carriage Services, Pool, The Buckle, Bolt Biotherapeutics and Titan Machinery Zacks -6.57%
May-27-22 08:00AM	Bolt Biotherapeutics to Present Ex Vivo Data Characterizing the Myeloid Cell Landscape in Solid Tumors at ASCO 2022 GlobeNewswire
May-26-22 06:52AM	The past year for Bolt Biotherapeutics (NASDAQ:BOLT) investors has not been profitable Simply Wall St.
May-13-22 08:28AM	The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma Zacks
May-12-22 04:05PM	Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights GlobeNewswire +5.41%
May-11-22 07:32AM	5 Biotech Stocks Set to Outpace Q1 Earnings Estimates Zacks -10.30%
Apr-07-22 08:00AM	Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference GlobeNewswire
Mar-30-22 04:05PM	Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights GlobeNewswire
Mar-08-22 04:30PM	Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022 GlobeNewswire
Feb-12-22 06:30AM	Companies Like Bolt Biotherapeutics (NASDAQ:BOLT) Are In A Position To Invest In Growth Simply Wall St.
Feb-02-22 08:00AM	Bolt Biotherapeutics to Participate in Upcoming February Conferences GlobeNewswire
Jan-27-22 01:43PM	7 Little-Known Penny Stocks That Could Take Off Any Moment InvestorPlace -12.40%
Jan-06-22 08:00AM	Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors GlobeNewswire -10.95%
Dec-17-21 06:14AM	3 Biotech Stocks That Sank: Are Any a Bad-News Buy? Motley Fool +5.32%
08:00AM	Loading…
Dec-16-21 08:00AM	Bolt Biotherapeutics Appoints Nicole Onetto, M.D., to Board of Directors GlobeNewswire
Dec-06-21 04:29PM	Why Bolt Biotherapeutics Stock Crashed Today Motley Fool -55.81%
09:23AM	Bolt Biotherapeutics Stock Halves on Mediocre Trial Data Investing.com
06:00AM	Bolt Biotherapeutics Reports Interim BDC-1001 Phase 1/2 Data Demonstrating a Safe and Well-tolerated Profile and Emerging Clinical Activity at the ESMO Immuno-Oncology Congress 2021 GlobeNewswire
Dec-02-21 06:00AM	Bolt Biotherapeutics to Present Interim Clinical Data on BDC-1001 Phase 1/2 Clinical Trial at ESMO Immuno-Oncology Congress 2021 GlobeNewswire
Nov-19-21 08:00AM	Bolt Biotherapeutics Announces Changes to its Board of Directors GlobeNewswire
Nov-12-21 07:00AM	Bolt Biotherapeutics Presents New Preclinical Data on Three Pipeline Programs at Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire
Nov-09-21 04:05AM	Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights GlobeNewswire -7.42%
Nov-08-21 08:00AM	Bolt Biotherapeutics to Present at Stifel 2021 Virtual Healthcare Conference GlobeNewswire
Nov-03-21 08:00AM	89bio Announces Appointment of Kathy LaPorte to its Board of Directors GlobeNewswire
Oct-01-21 08:00AM	Bolt Biotherapeutics to Present Updates on Three Pipeline Programs at the 2021 Society for Immunotherapy of Cancer Annual Meeting (SITC) GlobeNewswire +5.77%
Sep-08-21 07:30AM	Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid Tumors GlobeNewswire -6.38%
Sep-02-21 08:00AM	Bolt Biotherapeutics to Participate in Upcoming September Investor Conferences GlobeNewswire +5.07%
Aug-27-21 05:55AM	Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates Benzinga +9.71%
Aug-26-21 04:05PM	Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody ISAC Programs GlobeNewswire
Aug-16-21 06:26AM	Here's Why We're Not Too Worried About Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation Simply Wall St.
Aug-12-21 04:05PM	Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights GlobeNewswire +7.89%
Aug-02-21 04:32PM	European Uber Rival Firm Reaches $4.8B Valuation Following Fundraise For Grocery-Delivery Service: Report Benzinga +5.11%
Jul-20-21 12:42AM	Bolt Biotherapeutics, Inc. (BOLT): Are Hedge Funds Right About This Stock? Insider Monkey
Jun-22-21 08:16PM	Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Peloton Interactive, Inc. Newsfile
08:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Peloton Interactive, Inc. of Class Action Lawsuit and Upcoming Deadline - PTON PR Newswire
06:20PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, PTON and HMPT ACCESSWIRE
05:33PM	Peloton Interactive, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
03:41PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Peloton Interactive, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 28, 2021 - (PTON) Newsfile
02:10PM	PTON, RLX, UI SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits Filed on Behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
01:03PM	This AI home gym wants to replace your Peloton Yahoo Finance Video
12:30PM	CLASS ACTION UPDATE for PTON, ATER and WPG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:11PM	Peloton Plans Armband Heart-Rate Monitor in Wearables Push Bloomberg
12:00PM	PTON Investor Alert: Shareholder Class Action Deadline Approaching ACCESSWIRE
11:33AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Peloton Interactive, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 28, 2021 - PTON Newsfile
11:24AM	Berger Montague Reminds Investors of Approaching Deadline in Securities Fraud Class Action Against Peloton Interactive, Inc. (PTON); Lead Plaintiff Deadline is June 28, 2021 Newsfile
11:00AM	CCIV, PTON & PINS Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
09:24AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Peloton Interactive, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:00AM	Peloton Announces Corporate Wellness Offering PR Newswire
05:22AM	PTON LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Peloton Interactive, Inc. Newsfile
02:00AM	Komo Plant Based Foods Expands Plant-Based Meal Helpers(TM) Product Line and Announces New U.S. Trading Symbol KOMOF ACCESSWIRE
Jun-21-21 10:43PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
08:00PM	ROSEN, LEADING INVESTOR COUNSEL, Reminds Peloton Interactive, Inc. Investors of the Important June 28 Deadline in Securities Class Action Commenced by the Firm PTON GlobeNewswire
07:36PM	Peloton Deadline Alert Newsfile
05:43PM	PTON ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 28, 2021 in the Class Action Filed on Behalf of Peloton Interactive, Inc. Limited Shareholders Newsfile
04:12PM	Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Peloton Interactive, Inc. GlobeNewswire
02:25PM	Lawsuits Filed Against PTON, UI and RLX - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
01:40PM	INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of PTON, RLX, UI Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
01:30PM	FINAL DEADLINE NEXT WEEK: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Peloton Interactive, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:30AM	CLASS ACTION UPDATE for PTON, PCT and FREQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:23AM	Deadline Approaching for Peloton Interactive Investors: Berger Montague Reminds Investors of Approaching Deadline in Securities Fraud Class Action Against Peloton Interactive, Inc. (PTON); Lead Plaintiff Deadline is June 28, 2021 Newsfile
11:00AM	CCIV, PTON & PINS Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:25AM	SHAREHOLDER ALERT: PTON PCT FREQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:23AM	7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Peloton Interactive, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:51AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Peloton Interactive, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 28, 2021 - PTON Newsfile
Jun-20-21 03:25PM	PTON DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Peloton Interactive, Inc. of Deadline in Securities Fraud Class Action Lawsuit PR Newswire
03:00PM	PTON Investor Alert: Shareholder Lawsuit Filed Newsfile
12:37PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Peloton Interactive, Inc. of Class Action Lawsuit and Upcoming Deadline PTON GlobeNewswire
03:43AM	PELOTON DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Peloton To Contact Him Directly To Discuss Their Options GlobeNewswire
Jun-19-21 08:01PM	Peloton Shareholder Notice Newsfile
05:16PM	Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Peloton Interactive, Inc. Newsfile
Jun-18-21 10:50PM	SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTON, RLX, UI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
08:25PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTON, ATER and PRVB ACCESSWIRE
06:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Peloton Interactive, Inc. of Class Action Lawsuit and Upcoming Deadline PTON ACCESSWIRE
05:57PM	ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Peloton Interactive, Inc. Investors With Losses in Excess of $100K of Important June 28 Deadline in Securities Class Action Commenced by the Firm PTON Business Wire
12:00PM	INVESTOR DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Peloton Interactive, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTON, ATER and UI ACCESSWIRE
11:28AM	PTON Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against Peloton Interactive, Inc. ACCESSWIRE
11:00AM	CCIV, PTON & PINS Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
07:30AM	Peloton Analyst Trades Endorphins for Anxiety The Wall Street Journal
Jun-04-21 09:00AM	Bolt Biotherapeutics Presents Preliminary Results from Phase 1/2 Trial of Lead HER2-targeting Boltbody ISAC BDC-1001 at ASCO 2021 GlobeNewswire
Jun-02-21 08:00AM	Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration GlobeNewswire
May-13-21 04:05PM	Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights GlobeNewswire
May-05-21 02:31AM	What Kind Of Investors Own Most Of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT)? Simply Wall St.
Apr-10-21 08:30AM	Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001 GlobeNewswire

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Holdings A/S	10% Owner	Jul 13	Sale	2.00	800,000	1,600,000	3,703,991	Jul 15 04:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience